Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine
The problem

1 In 8 Women
will have breast cancer
at least once

BC is the most treatable cancer
but women, specially those with dense breast tissue, do not have reliable
screening methods available

It still remains the #1 cancer killer for women
81% of them want to get tested
for breast cancer
THE SOLUTION
We’re building a pain-free, radiation-free and accessible breast cancer test for them
Our Mission
Breast cancer is the most treatable cancer, yet it remains the #1 cancer killer for women, as 50% are detected too late. At The Blue Box, we’ve built a urine-based breast cancer test with a sensitivity of 88.42%, outperforming mammography by 15%-30%. We’ll run clinical trials in 2025 and launch in gynecology clinics by 2026.
Scientific Validation
During 3 years, we’ve collaborated with 7 hospitals, with over 450 women participating in our study
The Blue Box – Featured at













The Blue Box – Supported By:
















Join The Blue Box Family!
Do you want to be the first to know when The Blue Box will hit the market?
Subscribe to our newsletter and never miss out on The Blue Box journey!